ALGS vs MSFT: Which Stock is Better?
Side-by-side comparison of Aligos Therapeutics Inc and Microsoft Corp in 2026
ALGS
Aligos Therapeutics Inc
$6.98
MSFT
Microsoft Corp
$408.40
Key Metrics Comparison
| Metric | ALGS | MSFT | Winner |
|---|---|---|---|
| Market Cap | $40.98M | N/A | ALGS |
| P/E Ratio | N/A | 36.30 | MSFT |
| EPS (TTM) | $N/A | $13.70 | MSFT |
| Revenue Growth | -0.4% | 14.9% | MSFT |
| Gross Margin | -2486.8% | 68.8% | MSFT |
Analyze ALGS
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ALGS or MSFT a better investment?
Comparing ALGS and MSFT: Aligos Therapeutics Inc has a market cap of $40.98M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ALGS and MSFT?
ALGS (Aligos Therapeutics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ALGS or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ALGS or MSFT?
MSFT has higher revenue growth at 14.9% vs -0.4% for ALGS.
Which company is more profitable: ALGS or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.8% compared to -2486.8% for ALGS.
Which is the larger company: ALGS or MSFT?
Aligos Therapeutics Inc (ALGS) is larger with a market cap of $40.98M compared to N/A for MSFT.
Should I buy ALGS or MSFT in 2026?
Both ALGS and MSFT have investment merit. ALGS trades at $6.98 while MSFT trades at $408.40. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ALGS and MSFT stock?
Key differences: Market Cap ($40.98M vs N/A), P/E Ratio (N/A vs 36.3x), Revenue Growth (-0.4% vs 14.9%), Gross Margin (-2486.8% vs 68.8%).